<SEC-DOCUMENT>0001829126-25-001253.txt : 20250227
<SEC-HEADER>0001829126-25-001253.hdr.sgml : 20250227
<ACCEPTANCE-DATETIME>20250227160514
ACCESSION NUMBER:		0001829126-25-001253
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20250226
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250227
DATE AS OF CHANGE:		20250227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		25678646

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cyclacel_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cycc="http://cyclacel.com/20250226">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_cycc_cyclacel.com_20250226 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250226_20250226 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001130166 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000004" name="dei:EntityCentralIndexKey">0001130166</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cycc-20250226.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cycc:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cycc:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="text-align: center; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM</b> <b><span id="xdx_903_edei--DocumentType_c20250226__20250226_zP4gdJs9L3I1"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20250226__20250226_zceTQE83ajkj"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 26, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (date of earliest event reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="img_001.jpg" alt="" style="height: 99px; width: 250px"/></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20250226__20250226_zoTxsmbPzdY7"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000011" name="dei:EntityRegistrantName">Cyclacel Pharmaceuticals, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-style: normal; font-weight: normal">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><b><span style="font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250226__20250226_zNUYiUDxsp6h"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20250226__20250226_zqQAx4GHTb05"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000013" name="dei:EntityFileNumber">0-50626</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250226__20250226_z7wU9Dc1sNW3"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000014" name="dei:EntityTaxIdentificationNumber">91-1707622</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top"><span style="font-style: normal; font-weight: normal">(State or other
    jurisdiction of<br/>
incorporation or organization)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt; font-style: normal; font-weight: normal">(Commission<br/>
    File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-style: normal; font-weight: normal">(I.R.S. Employer<br/> Identification Number)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20250226__20250226_zILwaDzKvgdg"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000015" name="dei:EntityAddressAddressLine1">200 Connell Drive</ix:nonNumeric></span></b><b>,<span id="xdx_900_edei--EntityAddressAddressLine2_c20250226__20250226_zDbBOv1SIfYe"> <ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 1500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20250226__20250226_z7XjcjSiCYq9"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000017" name="dei:EntityAddressCityOrTown">Berkeley Heights</ix:nonNumeric></span></b><b>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20250226__20250226_zKs7PWXRRHMj"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b><b> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20250226__20250226_zs6tQkEaLQHf"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000019" name="dei:EntityAddressPostalZipCode">07922</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-style: normal; font-weight: normal">(Address
of principal executive offices) (Zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(<span id="xdx_90E_edei--CityAreaCode_c20250226__20250226_zm37ALxlUqX8"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000020" name="dei:CityAreaCode">908</ix:nonNumeric></span></b><b>) <span id="xdx_904_edei--LocalPhoneNumber_c20250226__20250226_zJVrpnsVtA31"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000021" name="dei:LocalPhoneNumber">517-7330</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s telephone number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90A_edei--WrittenCommunications_c20250226__20250226_zoRcUl6zYdqf"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Written communications pursuant
    to Rule 425 under the Securities Act (17 CFR 230.425)</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.95pt; text-indent: -17.95pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_905_edei--SolicitingMaterial_c20250226__20250226_zeIqCrdI3Cjh"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.95pt; text-indent: -17.95pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementTenderOffer_c20250226__20250226_zL3WMIBJ3f38"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250226__20250226_z5LFptMsELeb"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt; font-style: normal; font-weight: normal">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 38%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 20%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 38%"><span style="font-size: 10pt"><b>Name of each exchange on which registered </b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zik5t9jDf27g"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zwndnKHCkoa9"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember" id="Fact000027" name="dei:TradingSymbol">CYCC</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_90A_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zrudejFHqAQa"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zthSTtNccH37"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember" id="Fact000029" name="dei:Security12bTitle">Preferred Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zBapkDFp71Mc"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember" id="Fact000030" name="dei:TradingSymbol">CYCCP</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_90E_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zE1LpjJV0wQd"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20250226__20250226_zmqhU3RJBZp"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline"><b>Item
1.01 Entry into a <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Definitive Agreement</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;) entered into a settlement agreement with Dr. Samuel L. Barker,
a resigning director as described below in Item 5.02 and is incorporated by reference into this Item 1.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2025, the Nasdaq Stock Market notified the Company that it has regained compliance with the equity requirement in Listing
Rule 5550(b)(1) (the &#8220;Equity Rule&#8221;), as required by the Nasdaq Hearing Panel&#8217;s decision dated October 22, 2024. As
previously reported by the Company on Form 8-K, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on October
24, 2024, on October 15, 2024, the Company met with the Nasdaq Hearings Panel regarding the Company&#8217;s potential delisting from
The Nasdaq Stock Market as a result of its non-compliance with the Equity Rule. On October 22, 2024, the Company received the Nasdaq
Hearings Panel decision which granted the Company until December 24, 2024 to regain compliance with the Equity Rule. Following the Company&#8217;s
regaining compliance with the Equity Rule, in application of Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel
Monitor for a period of one year from February 25, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.03 Material Modification to Rights of Security Holders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information and disclosure in&#160;Item 5.01&#160;below regarding the voting rights of the Series C Convertible Preferred Stock and Series
D Convertible Preferred Stock is incorporated by reference into this&#160;Item 3.03.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;5.01
Changes in Control of Registrant.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
C and Series D Preferred Stock Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2025, David E. Lazar (the &#8220;Seller&#8221;), the interim Chief Executive Officer and Secretary of the Company, entered
into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with an investor, Datuk Dr. Doris Wong Sing Ee (the &#8220;Investor&#8221;)
pursuant to which the Investor agreed to purchase 1,000,000 shares of Series C Convertible Preferred Stock of the Company, $0.0001 par
value per share (the &#8220;Series C&#8221;) and such number of the 2,100,000 shares of Series D Convertible Preferred Stock of the Company,
$0.0001 par value per share (the &#8220;Series D&#8221;) currently held by Seller so that Purchaser shall hold seventy percent (70%)
of the issued and outstanding shares of the Company, which resulted in the issuance of 1,745,262 shares of Series D (collectively, the
Series C and Series D are the &#8220;Securities&#8221;). The transaction contemplated by the Purchase Agreement closed on February 26,
2025 (the &#8220;Closing Date&#8221;). Additionally, the Investor purchased and succeeded to all of the Seller&#8217;s rights and interests
under that certain securities purchase agreement between the Seller and the Company dated January 2, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the sale of the Securities, the Investor delivered $6,300,000 (the &#8220;Purchase Price&#8221;) less the holdback
amount of $100,000 (the &#8220;Holdback Amount&#8221;) to the escrow agent. The Purchase Price included a cash brokerage fee in the amount
of $800,000 (the &#8220;Broker Fee&#8221;) paid to Lighthouse Advisory Limited (&#8220;Broker&#8221;). The Holdback Amount will be held
back by the Investor for 120 days from the Closing Date to satisfy any indemnity and other agreed upon claims and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities are convertible into shares of the common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) of the Company
at the election of the Investor as follows: (i) the 1,000,000 shares of the Series C are convertible into 2,650,000 shares of Common
Stock, and (ii) 1,745,262 of the Series D are convertible into 191,978,820 shares of Common Stock currently held by Seller so that the
Investor shall hold 194,628,820 shares of Common Stock equivalent to approximately seventy percent (70%) of the issued and outstanding
shares of the Company, on an as-converted basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported by the Company on Form 8-K filed with the SEC on February 12, 2025, at a special meeting of stockholders held on
February 6, 2025 (the &#8220;Special Meeting&#8221;), the stockholders of the Company approved an amendment (the &#8220;Series C Amendment&#8221;)
to the Company&#8217;s certificate of designation designating the rights, preferences and limitations of the Company&#8217;s Series C
(the &#8220;Series C Certificate of Designation&#8221;). As described in the Company&#8217;s proxy statement for the Special Meeting,
the Series C Certificate of Designation provided that the Series C could not be converted or voted in a manner that would result in the
holder or his or her transferees or their affiliates holding or voting more than the lower of (i) the maximum percentage of the number
of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion
of the Series C Convertible Preferred Stock that could be issued to the holder without requiring a vote of the stockholders of the Company
under the rules and regulations of The Nasdaq Stock Market and (ii) 5% of the number of shares of common stock outstanding immediately
before the original issue date (the &#8220;Series C Ownership Limitation&#8221;), prior to the date that the Company&#8217;s stockholders
approved the issuance of shares of common stock to the holder thereof. The Series C Amendment removed such Series C Ownership Limitation
so that the shares of Series C Convertible Preferred Stock may be converted and voted without regard to such Series C Ownership Limitation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the approval of the Series C Amendment at the Special Meeting, the Company filed the Series C Amendment with the Secretary of State of
the State of Delaware on February 10, 2025. Except for the removal of the Series C Ownership Limitation, the Series C Amendment did not
make any other changes to the Series C Certificate of Designation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
also as previously reported by the Company on Form 8-K filed with the SEC on February 12, 2025, on February&#160;6, 2025, the Company&#8217;s
board of directors (the &#8220;Board&#8221;) and David Lazar approved an amendment to the Company&#8217;s Series D Convertible Preferred
Stock (the &#8220;Series D Amendment&#8221;) to the Company&#8217;s certificate of designation designating the rights, preferences and
limitations of the Company&#8217;s Series D (the &#8220;Series D Certificate of Designation&#8221; and together with the Series C Certificate
of Designation, the &#8220;Certificates of Designation&#8221;) prior to the issuance of any shares of Series D. The Series D Certificate
of Designation provided that the Series D Convertible Preferred Stock could not be converted or voted in a manner that would result in
the holder or his or her transferees or their affiliates holding or voting more than the lower of (i) the maximum percentage of the number
of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion
of the Series D Convertible Preferred Stock that could be issued to the holder thereof without requiring a vote of the stockholders of
the Company under the rules and regulations of The Nasdaq Stock Market and (ii) 49.99% of the number of shares of the common stock outstanding
immediately before the original issue date (the &#8220;Series D Ownership Limitation&#8221;), prior to the date that the Company&#8217;s
stockholders approve the issuance of shares of common stock to the holder thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series D Amendment removes such Series D Ownership Limitation so that the shares of Series D Convertible Preferred Stock may be converted
and voted without regard to such Series D Ownership Limitation. Following the Series D Amendment, the Company issued 2,100,000 shares
of Series D Convertible Preferred Stock to David Lazar pursuant to the Securities Purchase Agreement, dated as of January 2, 2025, by
and between the Company and David Lazar, which was previously filed with a current report on Form 8-K filed by the Company with the SEC
on January 6, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company filed the Series D Amendment with the Secretary of State of the State of Delaware on February 6, 2025. Except for the removal
of the Series D Ownership Limitation and related definitions, the Series D Amendment did not make any other changes to the Series D Certificate
of Designation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise
of Conversion Right</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, the Seller issued written notice to the Company to exercise the conversion rights related to the Series C and Series
D shares into Common Stock of the Company registered in the Investor&#8217;s name, as follows: (i) the conversion of 1,000,000 shares
of Series C into 2,650,000 shares of Common Stock of the Company; and (ii) the conversion of 1,745,262 shares of Series D into 191,978,820
shares of Common Stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities were sold in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (&#8220;Section
4(a)(2)&#8221;). The Investor in the Securities is an individual that is not an existing investor in the Company. The foregoing description
of terms and conditions of the Purchase Agreement does not purport to be complete and is qualified in its entirety by the full text of
the Purchase Agreement, which is attached hereto as Exhibit 10.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Assignment
and Assumption Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the consummation of the Purchase Agreement, the Seller and the Investor entered into an assignment and assumption agreement
(the &#8220;Assignment and Assumption Agreement&#8221;) as of February 26, 2025, pursuant to which Seller assigned to the Investor and
the Investor agreed to assume <span style="background-color: white">from Seller (as the assignor), that certain securities purchase agreement
(the &#8220;Lazar SPA&#8221;) between the Company and the Seller dated February 4, 2025. As previously reported on Form 8-K filed with
the SEC on </span>February&#160;6, 2025, the <span style="background-color: white">Lazar SPA</span> pertains to the issuance and sale
in a private placement of up to $8,000,000 (the &#8220;Lazar Purchase Price&#8221;) of shares of the Common Stock of the Company. Under
the Lazar SPA, the Company shall have the right, but not the obligation, to direct the Seller (as purchaser under the Lazar SPA), until
September&#160;30, 2026, to purchase up to the Lazar Purchase Price of Shares at a purchase price equal to the greater of (i) the consolidated
closing bid price immediately prior to the entry of this Agreement and (ii) the consolidated closing bid price on the business day immediately
preceding the applicable purchase date, in either $1,000,000 or $2,000,000 increments unless otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported on Form 8-K filed with the SEC on February 24, 2025, the Seller and the Company entered into an amendment to the
Lazar SPA (the &#8220;Amendment&#8221;) to amend the applicable purchase price to be the greater of (i) the consolidated closing bid
price immediately prior to the entry into the Lazar SPA and (ii) the consolidated closing bid price on the Trading Day (as defined in
the Lazar SPA) immediately preceding the applicable Purchase Date (as defined in the Lazar SPA) if such purchase occurs on a Trading
Day prior to close of market or the consolidated closing bid on the Trading Day of Purchase Date if it occurs following close of the
market on a Trading Day until the market opens on the next Trading Day. The Amendment also added a contractual six (6) month lock-up
for any Shares issued in all of the private placement offerings described in the Lazar SPA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of terms and conditions of the Assignment and Assumption Agreement does not purport to be complete and is qualified
in its entirety by the full text of the Assignment and Assumption Agreement, which is attached hereto as Exhibit 10.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Departure
of Chief Executive Officer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, David Lazar, the Company&#8217;s interim Chief Executive Officer, interim principal financial officer, interim principal
accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective
February 26, 2025.&#160;Mr. Lazar will continue his role as co-principal financial officer and co-principal accounting officer to assist
with the transition of the Company&#8217;s new Chief Financial Officer, as discussed below. Mr Lazar&#8217;s resignation was not the
result of any disagreement between Mr. Lazar and the Company on any matter relating to the Company&#8217;s operations, policies or practices.
In connection with Mr. Lazar&#8217;s departure, he will not be eligible to receive any severance benefits or any performance based bonus
compensation for the 2025 partial year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Appointment
of Chief Executive Officer and Director</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of February 26, 2025, the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve
as the Company&#8217;s principal executive officer. Datuk Dr. Doris Wong Sing Ee was also elected to the Board of the Company as of the effective date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk Dr. Doris Wong Sing Ee, aged 43, brings more than 20 years of management experience to her role as Chief Executive Officer of the Company across various
industries ranging from oil and gas, property development, solar, engineering, advertising, food and beverage, raw materials and more.
She specializes in business development, strategic consultancy and corporate advisory in mergers and acquisition and joint venture across
Malaysia, Singapore, China, Japan, Thailand and Indonesia. Since October 2020, Datuk Dr. Doris Wong Sing Ee has been serving as an Executive Director of
Metronic Global Bhd, an investment holding company, where she has been optimizing financial operations, establishing business goals,
advising the board of directors on organizational activities and executing special business projects. She has also been involved in various
investment opportunities in business diversification, generating new revenue and increasing shareholders&#8217; wealth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Datuk Dr. Doris Wong Sing
Ee has also been serving as the Executive Director of BSL Corporation Berhad (KLSE: BSLCORP) since May 2024, a public listed company
with its business segments constituting stamping and manufacturing of precision metal parts and fabrication of tools and dies, printed
circuit boards (PCB) assembly of all types of electronics and electrical components, devices and systems, fabrication and forging of
base metal components for consumer products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
Dr. Doris Wong Sing Ee served as an independent director and member of the audit committee and the compensation committee of Energem
Corp since from its initial public offering on November 16, 2021 until her appointment as Executive Director on January 27, 2023.
Following Energem Corp&#8217;s completion of a series of transactions that resulted in its business combination with Graphjet
Technology Sdn. Bhd. (Nasdaq: GTI), a Malaysian private limited company (&#8220;Graphjet&#8221;) on March 14, 2024, Datuk Dr. Doris Wong Sing Ee
served as a director of Graphjet until January 6, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since February 2017, Datuk Dr. Doris Wong Sing
Ee has been a non-independent non-executive director at Trive Property Group Bhd (0118.KL). Previously, from January 2019 to September
2020, Datuk Dr. Doris Wong Sing Ee served as Chief Corporate Officer in Metronic Engineering Sdn. Bhd. (0043.KL) where she oversaw HR
operations, set objectives for the HR team and helped shape the brand strategy of the company. Datuk Dr. Doris Wong Sing Ee served as
General Manager from 2015 to 2016 in Dai-Ichi Kikaku Sdn. Bhd. where she was overseeing and handling business development, client strategy
and direction, creative, production, media planning, procurement and research. From 2012 to 2015, Datuk Dr. Doris Wong Sing Ee served
as Strategic Business Consultant for JLPW Law Firm where she handled mergers and acquisitions and joint venture deals internationally
for various industries and from 2002 to 2012, Datuk Dr. Doris Wong Sing Ee started her career as a Managing Director at Niagamatic Sdn.
Bhd., where she controlled all business operations to give strategic guidance and directions to the board and staff to ensure the company
achieved its financial vison, mission and long-term goals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with her appointment, Datuk Dr.
Doris Wong Sing Ee may be entitled to compensation which has not yet been determined by the Company. There are no arrangements or understandings
with any other person pursuant to which Datuk Dr. Doris Wong Sing Ee was appointed as the Company&#8217;s Chief Executive Officer and
there are no family relationships between Datuk Dr. Doris Wong Sing Ee and any Company director or executive officer, and no arrangements
or understandings between Mr.&#160;Wong and any other person pursuant to which she was selected as an officer. Datuk Dr. Doris Wong Sing
Ee is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation&#160;S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Appointment
of Chief Financial Officer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of February 26, 2025, the Board appointed Kiu Cu Seng, as Chief Financial Officer and, in such role, he will serve as the Company&#8217;s
co-principal financial officer and co-principal accounting officer along with David Lazar until the effective date of his resignation
on the earlier of the filing date of the Company&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2024 or March
31, 2025, as discussed above. The Company&#8217;s Board also appointed Mr. Kiu as Executive Director and Secretary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Kiu&#160;(aged 36) brings significant accounting and audit experience involving publicly listed companies during his years working with
accounting standards. Mr. Kiu served as Energem Corp&#8217;s Chief Financial Officer from August 12, 2021 through its completion of a
series of transactions that resulted in its business combination with Graphjet on March 14, 2024. Since March 2021, Mr. Kiu has served
as Group Accountant for BCM Alliance Bhd, Sanichi Technology Bhd. and Trive Property Group Bhd. His responsibility is on group consolidation
issues. From June 2019 to February 2021, Mr. Kiu served as Manager in SBY &amp; Partners PLT (formerly known as Siew Boon Yeong &amp;
Associates) an established professional accounting organization providing a comprehensive range of services ranging from audit and assurance,
taxation and accounting where he specialized in auditing matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
June 2017 to February 2019, Mr. Kiu served as a Senior Auditor with Siew Boon Yeong &amp; Associates. Prior to that, from December 2016
to June 2017, Mr. Kiu served as a semi-senior auditor at the corporate compliance firm, Z. AMIN and he started his career in 2013 until
December 2016 with YTS &amp; Associate. Mr. Kiu graduated from Infrastructure University Kuala Lumpur in the year 2013 with bachelor&#8217;s
degree (with Honors) in Accounting and from Kuala Lumpur Infrastructure University College with a Diploma in Accounting in 2009.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his appointment, Mr. Kiu may be entitled to compensation which has not yet been determined by the Company. There are
no arrangements or understandings with any other person pursuant to which Mr. Kiu was appointed as the Company&#8217;s Chief Financial
Officer There are no family relationships between Mr. Kiu and any director, executive officer or person nominated or chosen by the Company
to become a director or executive officer. Additionally, there have been no transactions involving Mr. Kiu that would require disclosure
under Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resignation
of Certain Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coinciding
with the Closing Date of February 26, 2025, the following directors of the Company tendered their resignation or notice of resignation
from the Board: (i) Dr. Samuel L. Barker resigned as an independent director effectively immediately; (ii) Avraham Ben-Tzvi provided
notice that his resignation as an independent director will be effective upon the earlier of the filing date of the Company&#8217;s annual
report on Form 10-K for the fiscal year ended December 31, 2024 or March 31, 2025; (iii) Paul McBarron resigned as a non-independent
director effective immediately; (iv) David Natan provided notice that his resignation as an independent director will be effective upon
the earlier of the filing date of the Company&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2024 or March
31, 2025; and (iv) Spiro Rombotis resigned as a non-independent director effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Appointment
of Certain Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the resignation of Messers. Barker, McBarron and Rombotis, effective as of February 26, 2025, the Board appointed Chong
Kwang Fock to act as an Independent Director, as well as the Board appointments of Datuk Dr. Doris Wong Sing Ee and Kiu Cu Seng, as noted
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kwang Fock Chong&#160;is a Chartered Accountant
in Malaysia, and brings nearly 20 years of the working experience to the Company. He served as an Independent Director, Chair of the Audit
Committee and member of the Compensation Committee of Energem Corp since its initial public offering on November 16, 2021 until its business
combination with Graphjet on March 14, 2024. His experience includes auditing of public listed companies, multinationals and private limited
companies in various industries. Other than conducting statutory audit in Malaysia, he also performed audit for companies based in China
and the AIPAC region. He was also involved in Reporting Accountants&#8217; engagement on initial public offering exercise, due diligence,
reviewing financial forecast and projections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Mr. Chong serves as Auditors and Partner of KHLC PLT where his main
responsibility is reviewer and signing partner since October 2020. From July 2014 to September 2020, Mr. Chong served as Auditor and
Partner of SBY Partners PLT that provides audit and assurance services. His main responsibility was reviewer and signing partner. Mr.
Chong received his Diploma in 2002 from Tunku Abdul Rahman College in Financial Accounting. He achieved his Association of Chartered
Certified Accountants certification in 2005.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Settlement
Agreement with Director</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 26, 2025, the Company entered into
settlement agreements with Dr. Barker. Pursuant to the terms of the settlement agreement, Dr. Barker resigned his position as a member
of the Board of Directors, and any positions held on committees of the Board of Directors. In addition, Dr. Barker will receive his accrued
Board fees in full consideration of the release of claims against the Company and other promises and covenants set forth in the settlement
agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the settlement agreement, the Company will provide continuing indemnification to Dr. Barker in a manner consistent with
that which was in place as of the effective date of the settlement agreement, and will cause to be maintained in effect the Company&#8217;s
existing director and officer liability insurance pursuant to the Company&#8217;s tail insurance coverage and will not modify its governing
documents to modify Dr. Barker&#8217;s rights under such policy, as further set forth in the settlement agreement. The settlement agreement
contains a mutual non-disparagement clause.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of terms and conditions of the settlement agreement does not purport to be complete and is qualified in its entirety
by the full text of the settlement agreement, which is attached hereto as Exhibit 10.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="cyclacel_ex10-1.htm">Securities Purchase Agreement dated February 11, 2025 by and between David Elliot Lazar and Doris Wong Sing Ee</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="cyclacel_ex10-2.htm">Assignment and Assumption Agreement dated February 26, 2025 by and between David Elliot Lazar and Doris Wong Sing Ee</a></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="cyclacel_ex10-3.htm">Settlement and Release Agreement dated February 26, 2025 by and between Dr. Samuel Barker and the Company</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="cyclacel_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued February 27, 2025</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 27, 2025</span></td>
    <td colspan="3" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyclacel
    Pharmaceuticals, Inc.</b></span></td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
Datuk Dr. Doris Wong Sing Ee</i></span></td></tr>
  <tr>
    <td style="text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="text-align: left; vertical-align: top; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</span></td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->



     <!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kU1uwjAQRk+QO4yiLhE4rmCRHY0oqgoVCgh16yZDa5F4orFD4Ui9ZR2nSTetZcmy5nvz/BPHk3hNj7pChteHfAMHrJtKOYQcT8hoCvSJ7Ok5Bb/m+K6tY2Vc2A5gRp5Bz8yncq58IUQv2mKZgpAzsZjJOYhFei9huY2jrp6ROekSjdOqAmVK2DE1rNEpvvUdDupKhupbUB2RrSaTQjIVffkLpEgkvNBFfRKfLWw2WRxNwojiNVPb+NTq6tB0JKwqrL3O9vTvDKcpWuuoTnfcXZqx3DsqzmIqRLJTfFRVi1us35B9NBFSJmL5c4qRgIBM4C5Q0CiGS8f9YfHPVZMJ+aF7r0Lefyj+T9Vjg2cUjEb/EbbDB+M3+nOLGg== -->

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cyclacel_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
  <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Agreement (the &ldquo;<U>Agreement</U>&rdquo;) is entered into as of this 11th day of February&nbsp;2025 by and between David Elliot Lazar, whose address is 44, Tower 100 The Towers, Winston Churchill, San Francisco, Paitilla, Panama City, Panama 07196 (&ldquo;<U>Seller</U>&rdquo;), and Datuk Doris Wong, an individual residing in Kuala Lumpur, Malaysia (&ldquo;<U>Purchaser</U>&rdquo;). Seller and Purchaser may be referred to herein as the &ldquo;<U>Parties</U>&rdquo; and each of them separately as a &ldquo;<U>Party</U>.&rdquo;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, Seller, the interim Chief Executive Officer of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Issuer</U>&rdquo; and, together with its subsidiaries, the &ldquo;<U>Group</U>&rdquo;), is the holder of 1,000,000 shares of Series C Convertible Preferred Stock, $0.0001 par value per share (the &ldquo;<U>Series C</U>&rdquo;) of the Issuer and 2,100,000 shares of Series D Convertible Preferred Stock (the &ldquo;<U>Series D</U>&rdquo;), $0.0001 par value per share; and</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>the Purchaser proposes to purchase, and the Seller proposes to sell all of his interest and rights in (i) 1,000,000 shares of the Series C (convertible into 2,650,000 shares of common stock of the Issuer), and (ii) 1,745,262 of the Series D (convertible into 191,978,820 shares of common stock of the Issuer) currently held by Seller so that Purchaser shall hold 194,628,820 shares of common stock of the Issuer equivalent to approximately seventy percent (70%) of the issued and outstanding shares of the (together, the &ldquo;<U>Securities</U>&rdquo;) Issuer, on an as-converted basis, as well as all of the Seller&rsquo;s applicable protections in that certain Securities Purchase Agreement dated as of January&nbsp;2, 2025, between Seller and Issuer, pursuant to which, <I>inter alia</I>, the Seller had acquired the Securities (the &ldquo;<U>Series C&amp;D SPA</U>&rdquo;; and together with the Securities, the &ldquo;<U>Sold Assets</U>&rdquo;), all pursuant to this Agreement; and</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration of these premises and the mutual agreements contained in this Agreement, the Parties agree as follows:</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<B><U>Agreement to Purchase and Sell</U></B><U></U>. Subject to the terms and conditions of this Agreement, upon execution hereof, Seller shall sell, assign, transfer, convey, and deliver to Purchaser, the Securities and any and all rights in the Sold Assets to which Seller is entitled, and by doing so, Seller shall be deemed to have assigned all of his rights, title and interest in and to the Sold Assets to Purchaser, assuming the entire Purchase Price is paid in accordance with this Agreement. Such sale of the Securities shall be evidenced by book entry statements thereof or stock certificates, duly endorsed in blank or accompanied by stock powers duly executed in blank or other instruments of transfer in form and substance reasonably satisfactory to the Issuer and Purchaser, and a duly executed assignment of the Series C&amp;D SPA in the form attached hereto as <U>Exhibit C</U> (together, the &ldquo;<U>Closing Transfer Documents</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<B><U>Consideration</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a)&nbsp;In consideration for the sale of the Sold Assets, the Purchaser shall deliver to the Escrow Agent (as defined in the Escrow Agreement), Six Million Three Hundred Thousand Dollars (USD $6,300,000) (the &ldquo;<U>Purchase Price</U>&rdquo;) less the Holdback (as defined below), which includes a cash brokerage fee in the amount of Eight Hundred Thousand United States Dollars (USD $800,000) (the &ldquo;<U>Broker Fee</U>&rdquo;) to be paid to Lighthouse Advisory Limited (&ldquo;<U>Broker</U>&rdquo;), pursuant to the Escrow Agreement, in the form attached hereto as <U>Exhibit B</U> (the &ldquo;<U>Escrow Agreement&rdquo;</U><B><U>)</U></B>. The Purchase Price (less the Holdback) shall be disbursed/released upon the Closing (as defined below). For avoidance of doubt it is hereby clarified and agreed by the parties hereto that failure by the Purchaser to provide the Seller with confirmation of the transmission of the Escrow Amount to the Escrow Agent by the Escrow Amount Deposit Deadline (as defined in the Escrow Agreement) shall render this agreement null and void <I>ab initio</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b)&nbsp;$100,000 of the Purchase Price, including any interest accrued thereon (altogether, the &ldquo;<U>Holdback Amount</U>&rdquo;), shall be held back by the Purchaser at the Closing pursuant to Section&nbsp;3 and the Parties&rsquo; right receive the amounts so held back shall be subject to the terms and conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<B><U>Closing; Deliverables</U></B><U></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Closing shall be held upon satisfaction of the following closing conditions: (the &ldquo;<U>Closing</U>&rdquo;) (i) receipt by the Escrow Agent of the Closing Transfer Documents, or other instruments of transfer in form and substance reasonably satisfactory to the Purchaser, including <U>Exhibit A</U> for the appointment of three (3) designees of the Purchaser, and (ii) completion of the deliverables set forth in Section&nbsp;3(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) At the Closing, the Seller shall deliver to the Purchaser (i) evidence of the Purchaser&rsquo;s ownership of the Series C and Series D, including the (A) documentation pursuant to which the Seller received the Series C and Series D, (B) any documentary evidence of the due recordation in the Issuer&rsquo;s share register of the Purchaser&rsquo;s full and unrestricted title to such Series C and Series D, (C) this Agreement duly executed by the Seller, and (D) evidence of the appointment of the Purchaser&rsquo;s three (3) designees as directors of the Issuer and the resignation of three (3) current Directors of the Issuer, subject to payment of all accrued and unpaid Director fees and bonuses, (ii) removal of any beneficial ownership limitation provisions in the certificate of designations, preferences, rights and limitations of the Series D, (iii) evidence satisfactory to the Purchaser of the filing and acceptance by the Delaware Secretary of State of the amended and restated certificate of designations, preferences, rights and limitations of the Series D removing any beneficial ownership limitation provisions therein, (iv) evidence satisfactory to the Purchaser that the Issuer has delivered to the transfer agent of the Issuer the applicable documentation in order to process the full conversion of the Series C and Series D in the name of the Purchaser, (v) evidence satisfactory to the Purchaser that all approvals and notifications have been obtained or sent, including without limitation, applicable stockholder and Nasdaq approvals and notifications, (vi) correspondence from Nasdaq that the Issuer has satisfied the equity requirement under Nasdaq listing rule&nbsp;5550(b)(1) related to stockholder equity non-compliance of the Issuer, (vii) bank statements and other documents deemed reasonable by the Purchaser showing the cash balance and financial position of the Issuer, including any liabilities, as set forth in the flow of funds in <U>Schedule&nbsp;5.11,</U> (viii) evidence satisfactory to the Purchaser that the bank signatories of all banking accounts of the Issuer has been changed to the Purchaser or the Purchaser&rsquo;s designated representatives, (ix) evidence satisfactory to the Purchaser that the Judgment Sum in the New Jersey Judgment No.: DJ 216892 18 has been paid and satisfied in full, (x) evidence satisfactory to the Purchaser that there shall be no obligation upon the Issuer for salaries, commissions or fees payable to employees, consultants, agents or other professionals except as set forth in the flow of funds in <U>Schedule&nbsp;5.11</U>, (xi) evidence satisfactory to the Purchaser that the Issuer has not committed to sell or sold any securities under the securities purchase agreement dated as of February&nbsp;4, 2025 between the Issuer and the Seller (the &ldquo;<U>Lazar Securities Purchase Agreement</U>&rdquo;), and/or the securities purchase agreement dated as of February&nbsp;5, 2025 between the Issuer and Helena Special Opportunities 1 Ltd., (xii) a continuing directors and officers insurance policy covering the new directors and officers of the Issuer after the Closing, and (xiii) such other documents as may be required under applicable law or reasonably requested by the Purchaser (the &ldquo;Seller Closing Deliverables&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify">(c) At the Closing, the Purchaser shall deliver to Seller (i) this Agreement duly executed by the Purchaser, (ii) evidence of the acceptance of the appointment of Purchaser&rsquo;s three (3) designees as directors of the Issuer, and (iii) evidence on the assignment by Seller of the Lazar Securities Purchase Agreement to the Purchaser or an agreement by the Purchaser in writing, whereby the Purchaser agrees to be bound to the Issuer by the provisions of the Lazar Securities Purchase Agreement in lieu of the Seller (the &ldquo;<U>Purchaser Closing Deliverables</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify">(d) The term of the Holdback Amount shall be 120 days from the Closing Date (the &ldquo;<U>Holdback Term</U>&rdquo;). All Losses suffered by the Issuer and/or the Purchaser related to the failure to obtain any Required Approvals shall be first made or set-off against the Holdback Amount. Upon the later of the obtaining any Required Approvals requested by Nasdaq or the end of the Holdback Term, the Holdback Amount less any Losses suffered, if any, shall be paid to the Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<B><U>Representations and Warranties of Seller</U></B><U></U>. As an inducement to Purchaser to enter into this Agreement and to consummate the transactions contemplated herein, Seller represents and warrants to Purchaser, as of the date hereof and as of the Closing, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;<U>Authority</U>. Seller has the right, power, authority, and capacity to execute and deliver this Agreement, consummate the transactions contemplated hereby, and perform his obligations under this Agreement. Subject to execution and delivery by Purchaser, this Agreement constitutes the legal, valid, and binding obligations of Seller, enforceable against Seller in accordance with the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>Ownership</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) Seller is the sole record and beneficial owner of the Sold Assets, has good and marketable title to the Sold Assets, free and clear of all Encumbrances (hereafter defined), other than applicable restrictions under applicable securities laws, and has or will have full legal right and power to sell, transfer and deliver the Sold Assets to Purchaser in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) &ldquo;<U>Encumbrances</U>&rdquo; means any liens, pledges, hypothecations, charges, adverse claims, options, preferential arrangements or restrictions of any kind, including, without limitation, any restriction of the use, voting, transfer, receipt of income or other exercise of any attributes of ownership. Upon the execution and delivery of this Agreement, Purchaser will receive good and marketable title to the Sold Assets, free and clear of all Encumbrances, other than restrictions imposed pursuant to any applicable securities laws and regulations, and have been issued in compliance with all federal and state securities laws. The shares of common stock of the Issuer underlying the Securities will be duly and validly issued, fully paid, and nonassessable, free and clear of any Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;<U>Valid Issuance</U>. The Sold Assets are duly authorized, duly designated (as applicable), validly issued, fully paid and non-assessable, and were not and will not be issued in violation of any preemptive or similar rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;<U>No Conflict</U>. None of the execution, delivery, or performance of this Agreement, and the consummation of the transactions contemplated hereby, conflicts or will conflict with, or (with or without notice or lapse of time, or both) result in a termination, breach or violation of (i) any instrument, contract or agreement to which the Seller is a party or by which any of his assets is bound, or to which the Sold Assets are subject; or (ii) any federal, state, local or foreign law, ordinance, judgment, decree, order, statute, or regulation, or that of any other governmental body or authority, applicable to the Seller or the Sold Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;<U>No Consent</U>. Except as required by applicable securities laws, no consent, approval, authorization or order of, or any filing or declaration with any governmental authority or any other person is required for the consummation by the Seller of any of the transactions on its part contemplated under this Agreement. As of the Closing, the Issuer has obtained all the Required Approvals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;<U>No Other Interest</U>. Neither the Seller nor any of his affiliates has any interest, direct or indirect, in any shares of capital stock or other equity in the Issuer, other than the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;<U>Capitalization</U>. The authorized capital of the Issuer (the &ldquo;<U>Authorized Stock</U>&rdquo;), as of execution of this Agreement, consists of 250,000,000 shares of common stock, par value $0.001, of which a total of (i) 11,256,133 shares are issued and outstanding, (ii) 1,269,485 shares are pending issuance to Armistice Capital Master Fund Ltd., (iii) 181,951 shares are pending issuance to Helena Special Opportunities 1 Ltd., and 5,000,000 shares of preferred stock, par value $0.001, of which a total of (A) 135,273 6% Convertible Exchangeable shares are outstanding, convertible into 3 shares of common stock, (B) 264 Series A convertible preferred stock shares are outstanding, convertible into 440 shares of common stock, (C) 1,000,000 shares of the Series C, and (D) 2,100,000 shares of the Series D. <U>Schedule&nbsp;4.7</U> sets forth the fully diluted capitalization of the Issuer. Except as disclosed on <U>Schedule&nbsp;4.7</U>, no person, firm or corporation has any right, agreement, warrant or option, present or future, contingent or absolute, or any right capable of becoming a right, agreement or option to require the Issuer to issue any shares in its capital or to convert any securities of the Issuer or of any other company into shares in the capital of the Issuer. There are no outstanding securities or instruments of the Issuer that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Seller or the Issuer is or may become bound to redeem a security of the Issuer. Except for the Required Approvals, no further approval or authorization of any stockholder, the board of directors of the Issuer or other person is required for the issuance and sale of the Sold Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;<U>Filings</U>. The Issuer has filed all reports and other materials (the &ldquo;<U>Reports</U>&rdquo;) required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the &ldquo;<U>Exchange Act</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such Reports prior to the expiration of any such extension. Where a Report has been untimely filed, neither the Seller nor the Issuer has received any indication that the Securities and Exchange Commission or any other governmental or regulatory authority intends to take the position that the Issuer is in breach of the Exchange Act despite such filing. In the event the Seller and/or the Issuer receive any notification from the Securities and Exchange Commission or any other governmental or regulatory authority on any intention to claim the Issuer is in breach of the Exchange Act for any late filings, the Seller and/or Issuer shall forthwith notify the Purchaser of the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;<U>Reports</U>. As of their respective dates, the Reports complied in all material respects with the requirements of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the &ldquo;<U>Securities Act</U>&rdquo;) and the Exchange Act, as applicable, and none of the Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. To the Seller&rsquo;s knowledge, the Issuer is not an issuer subject to Rule&nbsp;144(i) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;<U>Nasdaq</U>. The Issuer&rsquo;s common stock is listed on The Nasdaq Stock Market LLC (&ldquo;<U>Nasdaq</U>&rdquo;). Other than (i) the notice from Nasdaq indicating that the Issuer was not in compliance with the minimum stockholders&rsquo; equity requirement for continued listing on Nasdaq and was therefore not in compliance with Nasdaq Listing Rule&nbsp;5550(b)(1) requiring companies listed on the Nasdaq Capital Market to maintain stockholders&rsquo; equity of at least $2,500,000 or to meet the alternatives of market value of listed securities or net income from continuing operations, as reported by the Issuer on a Current Report on Form 8-K, dated October&nbsp;24, 2024 and (ii) the notice from Nasdaq notifying the Issuer that, based upon the closing bid price of the Issuer&rsquo;s Common Stock for the last 30 consecutive business days, the Common Stock did not meet the minimum bid price of $1.00 per share required by Nasdaq Listing Rule&nbsp;5550(a)(2), initiating an automatic 180 calendar-day grace period for the Issuer to regain compliance, as reported by the Issuer on a Current Report on Form 8-K, dated December&nbsp;12, 2024, the Issuer is currently in compliance with all other Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;<U>Anti-Dilution Rights</U>. Other than as disclosed on <U>Schedule&nbsp;4.7</U> and <U>Schedule&nbsp;4.11</U>, the Issuer is not a party to or bound by any agreement or understanding granting anti-dilution rights to any person with respect to any of its equity or debt securities; no person has a right to purchase or acquire or receive any equity or debt security of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;<U>Further Assistance</U>. The Seller agrees to execute and deliver such other documents and to perform such other acts as shall be necessary to effectuate the purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;<U>Litigation</U>. There are no actions, suits, proceedings, judgments, claims or investigations pending or threatened in writing by or against the Issuer or affecting the Issuer or its properties, at law or in equity, before any court or other governmental agency or instrumentality, domestic or foreign, or before any arbitrator of any kind. To the knowledge of the Seller after due and careful inquiry, there is no default on the part of the Issuer with respect to any judgment, order, writ, injunction, decree, award, rule or regulation of any court, arbitrator, or governmental agency or instrumentality or any circumstance which would result in the discovery of such default. There has not been, and to the knowledge of the Seller, there is not pending or contemplated, any investigation by the Securities Exchange Commission involving the Issuer or any current or former director or executive officer of the Issuer. In the event the Seller and/or the Issuer receive any notification and/or letters threatening to commence any actions, suits, proceedings, judgments, claims or investigations against the Issuer or affecting the Issuer or its properties, the Seller shall no later than two (2) business days, notify the Purchaser of the potential actions pending and/or threatened against the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;<U>Liabilities</U>. Other than as disclosed in the Reports, there are no trade payables, accrued expenses, liabilities, taxes, obligations or commitments which the Issuer would be required to accrue or reflect in its financial statements pursuant to GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.15&nbsp;<U>Tax Returns</U>. The Issuer has filed all state, federal or local income and/or franchise tax returns required to be filed by it from inception to the date hereof. Each such income tax return reflects the taxes due for the period covered thereby, except for amounts which, in the aggregate, are immaterial. In addition, to the knowledge of the Seller after due and careful inquiry, all such tax returns are correct and complete in all material respects. All taxes of the Issuer which are (i) shown as due on such tax returns, (ii) otherwise due and payable or (iii) claimed or asserted by any taxing authority to be due, have been paid. There are no liens for any taxes upon the assets of the Issuer, other than statutory liens for taxes not yet due and payable. To the knowledge of the Seller after due and careful inquiry, there are no proposed or threatened tax claims or assessments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.16&nbsp;<U>Books and Records</U>. The books and records, financial and otherwise, of the Issuer are in all material aspects complete and correct and have been maintained in accordance with good business and accounting practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.17&nbsp;<U>Financial Statements</U>. The financial statements of the Issuer included in the Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Securities Exchange Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Issuer and its consolidated subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. There are no off-balance sheet arrangements to which the Issuer or any of its subsidiaries is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.18&nbsp;<U>Undisclosed Liabilities</U>. As of the date of this Agreement, there are no liabilities or obligations of any kind, whether accrued, contingent, absolute, inchoate or otherwise (collectively, &ldquo;<U>Liabilities</U>&rdquo;) of the Issuer or any of its subsidiaries, individually or in the aggregate, that are required to be recorded or reflected on a balance sheet prepared in accordance with GAAP, other than Liabilities reflected or reserved against in the financial statements (or the notes thereto) included in the Issuer&rsquo;s Quarterly Report on Form 10-Q for the period ended September&nbsp;30, 2024. Except as set forth in <U>Schedule&nbsp;4.18</U>, if provided, there are no Liabilities of the Issuer or any of its subsidiaries individually in excess of $10,000 or that in aggregate exceed $25,000 that will remain following the Issuer&rsquo;s settlement of outstanding Liabilities as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.19&nbsp;<U>Absence of Material Adverse Effect</U>. Since the date of the Issuer&rsquo;s latest audited financial statements filed with the Securities and Exchange Commission pursuant to the Exchange Act on Form 10-Q, there has been no effect which, individually or in the aggregate with any one or more other effects, would reasonably be expected to result in (i) a material adverse effect on the business, assets, liabilities, results of operations or financial condition of the Group, or (ii) a material adverse effect on the legality, validity or enforceability of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.20&nbsp;<U>Full Disclosure</U>. To the knowledge of the Seller after due and careful inquiry, no representation or warranty of the Seller to Purchaser in this Agreement contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements herein, in light of the circumstances in which they were made, not misleading. There is no fact known to the Seller that has specific application to the Sold Assets or the Issuer that materially adversely affects or, as far as can be reasonably foreseen, materially threatens the Sold Assets or the Issuer that has not been set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.21&nbsp;<U>Affiliate Status</U>. The Seller is an &ldquo;affiliate,&rdquo; as defined in Rule&nbsp;144(a), promulgated under Section&nbsp;4(a)(1) of the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.22&nbsp;<U>Employees, Directors and Officers</U>. The Issuer and the Seller have not entered into any employment or independent contractor agreements with any individuals or entities, or any option agreements or warrants, grants or promises for the issuance of the Authorized Stock, except as otherwise set forth in <U>Schedule&nbsp;4.22</U> and included under the Employee &amp; Director equity awards line in <U>Schedule&nbsp;4.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.23&nbsp;<U>Required Approvals</U>. On or before the Closing Date, the Issuer and the Seller shall have obtained any and all consents, approvals, notifications, authorizations, waivers or orders of or, given any notice to, or made any filing or registration with, any court or other federal, state, local or other governmental authority, Nasdaq, Issuer&rsquo;s board of directors and stockholders in connection with the issuance and sale of the Securities and the rights underlying the Series C&amp;D SPA to the Purchaser, and the issuance or potential issuance of the Securities resulting in a change of control of the Issuer (&ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.24&nbsp;<U>Offering Exemption</U>. The offer, sale and issuance of the Securities to be issued in conformity with the terms of this Agreement constitute transactions which are exempt from the registration requirements of the Securities Act and from all applicable state registration or qualification requirements. Subject to the receipt of the Required Approvals and assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in Section&nbsp;5, the issuance and sale of the Securities hereunder will not contravene the rules and regulations of the Nasdaq. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in Section&nbsp;5, the issuance and sale of the Securities by the Seller to the Purchaser is exempt from the prospectus requirements of applicable securities laws of the location of the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.25&nbsp;<U>Certain Fees</U>. Except for the Broker Fee, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Seller to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other person with respect to the transactions contemplated by the Agreement. The Purchaser shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.26&nbsp;<U>Foreign Corrupt Practices</U>. Neither the Seller nor the Issuer, nor to the knowledge of the Seller, any agent or other person acting on behalf of the Seller or the Issuer, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Issuer (or made by any person acting on its behalf of which the Issuer is aware) which is in violation of law or (iv) violated in any material respect any provision of Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.27&nbsp;<U>Office of Foreign Assets Control</U>. Neither the Issuer nor the Seller nor, to the Seller&rsquo;s knowledge, any director, officer, agent, employee or affiliate of the Issuer or any subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.28&nbsp;<U>Money Laundering</U>. The operations of the Groups are and have been conducted at all times in compliance in all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no action or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Group with respect to the Money Laundering Laws is pending or, to the knowledge of the Seller, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.29&nbsp;<U>Flow of Funds</U>. The Issuer&rsquo;s anticipated flow of funds described in <U>Schedule&nbsp;5.11</U> attached hereto shall be substantially the same from the date of execution of this Agreement until the Closing. The Seller understands and acknowledges that the Purchaser has agreed to enter into this Agreement substantially relying on the representations made by the Seller regarding the anticipated flow of funds in <U>Schedule&nbsp;5.11</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<B><U>Representations and Warranties of Purchaser</U></B><U></U>. As an inducement to Seller to enter into this Agreement and to consummate the transactions contemplated herein, Purchaser represents and warrants to Seller as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Authority</U>. Purchaser has the right, power, authority and capacity to execute and deliver this Agreement, to consummate the transactions contemplated hereby and to perform its obligations under this Agreement. Subject to execution and delivery by Seller, this Agreement constitutes the legal, valid and binding obligations of Purchaser, enforceable against Purchaser in accordance with the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>No Consent</U>. No consent, approval, authorization or order of, or any filing or declaration with any governmental authority or any other person is required for the consummation by Purchaser of any of the transactions on its part contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;<U>No Conflict</U>. None of the execution, delivery, or performance of this Agreement, and the consummation of the transactions contemplated hereby, conflicts or will conflict with, or (with or without notice or lapse of time, or both) result in a termination, breach or violation of (i) any instrument, contract or agreement to which Purchaser is a party or by which it is bound; or (ii) any federal, state, local or foreign law, ordinance, judgment, decree, order, statute, or regulation, or that of any other governmental body or authority, applicable to Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;<U>Potential Loss of Investment</U>. The Purchaser understands that an investment in the Sold Assets is a speculative investment that involves a high degree of risk and the potential loss of its entire investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;<U>Receipt of Information</U>. The Purchaser has received all documents, records, books, and other information pertaining to the investment that the Purchaser has requested. Purchaser has reviewed the publicly available information regarding the Issuer, which can be located on sec.gov or otherwise distributed to the public in compliance with Regulation FD and the State of Delaware Secretary of the State website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;<U>No Advertising</U>. At no time was the Purchaser presented with or solicited by any leaflet, newspaper or magazine article, radio or television advertisement, or any other form of general advertising or solicited or invited to attend a promotional meeting otherwise than in connection and concurrently with such communicated offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;<U>Investment Experience</U>. The Purchaser (either by itself or with its advisors) is (i) experienced in making investments of the kind described in this Agreement, (ii) able to afford the entire loss of its investment in the Securities, and (iii) is a qualified &ldquo;accredited investor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.8&nbsp;<U>Investment Purposes</U>. The Purchaser is acquiring the restricted Securities for its own account as principal, not as a nominee or agent, and no other person has a direct or indirect beneficial interest in the amount of restricted Securities Purchaser is acquiring herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.9&nbsp;<U>Restrictive Legends</U>. The Purchaser acknowledges that the Securities (including any common stock of the Issuer into which the Series C or Series D may be converted) were and will be issued pursuant to exemptions from registration under the Securities Act, and are also deemed to be &ldquo;control securities&rdquo;, and shall each bear legends stating that transfer of those Securities is restricted, substantially as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT. TRANSFER OF THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION/EXERCISE OF THIS SECURITY IS PROHIBITED, EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.10&nbsp;<U>Intentionally Omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.11&nbsp;<U>Flow of Funds</U>. The Purchaser has reviewed the Issuer&rsquo;s anticipated flow of funds described in <U>Schedule&nbsp;5.11</U> hereto. The Purchaser understands that such flow of funds shall occur or be processed at or around the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.12&nbsp;<U>Minimum Bid Price Deficiency</U>. The Purchaser is aware of the Issuer&rsquo;s minimum bid price deficiency disclosed in Section&nbsp;4.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<B><U>Covenants</U></B><U></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.1&nbsp;<U>Minimum Bid Price Deficiency</U>. The Purchaser shall take commercially reasonable steps to cure the minimum bid price deficiency within the time frame defined by Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.&nbsp;<B><U>Indemnification</U></B><U></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.1&nbsp;<U>Indemnification relating to Agreement</U>. The Seller and the Purchaser shall indemnify and hold harmless the other Party and such Party&rsquo;s agents, beneficiaries, affiliates, representatives and their respective successors and assigns (collectively, the &ldquo;<U>Indemnified Persons</U>&rdquo;) from and against any and all damages, losses, liabilities, claims, contingencies, taxes and costs and expenses (including, without limitation, attorneys&rsquo; fees and costs) (collectively, &ldquo;<U>Losses</U>&rdquo;) resulting directly or indirectly from (a) any inaccuracy, misrepresentation, or breach of any of the representations and warranties of such party in this Agreement, or any actions, omissions or statements of fact inconsistent with, in any material respect, any such representation or warranty, and (b) any failure by such Party to perform or comply with any agreement, covenant or obligation in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.2&nbsp;<U>Indemnification relating to Business</U>. The Seller shall indemnify and hold harmless the Purchaser and its agents, beneficiaries, affiliates, representatives, and successors and assigns (the &ldquo;<U>Indemnified Purchaser Parties</U>&rdquo;) against any Losses arising from third-party claims against Purchaser or the Group relating to the period prior to the Closing, where there has been a breach of Section&nbsp;4.18 or where any Liabilities of the Group relating to the period prior to the Closing are borne by the Group or an Indemnified Purchaser Party after the Closing, then Seller shall be liable for the related Loss with a cap on the liability up to the Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.3&nbsp;<U>Survival</U>. All representations, warranties, covenants and agreements of the Parties contained herein or in any other certificate or document delivered pursuant hereto shall survive the date hereof until the expiration of the applicable statute of limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.&nbsp;<B><U>Miscellaneous</U></B><U></U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;<U>Further Assurances</U>. From time to time, whether at or following the Closing, each party shall make reasonable commercial efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary, proper or advisable, including as required by applicable laws, to consummate and make effective as promptly as practicable the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;<U>Notices</U>. All notices or other communications required or permitted hereunder shall be in writing and shall be deemed duly given (a) if by personal delivery, when so delivered, (b) if sent through an express delivery service, the day shown by such delivery service that the notice was delivered or, in the absence of such notice, four days after being so sent to the respective addresses of the Parties as indicated on the signature page hereto, and (c) if by email, on the day the email is sent (provided the sender receives no automatically generated notice of non-delivery). Any party may change the address or email address to which notices and other communications hereunder are to be delivered by giving the other Parties notice in the manner herein set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;<U>Choice of Law; Jurisdiction</U>.
This Agreement shall be governed, construed and enforced in accordance with the laws of the State of New York, without giving effect
to principles of conflicts of law. Each of the Parties agrees to submit to the jurisdiction of the federal courts located in the Borough
of Manhattan in New York City in any actions or proceedings arising out of or relating to this Agreement. Each of the Parties, by execution
and delivery of this Agreement, expressly and irrevocably (i) consents and submits to the personal jurisdiction of any of such courts
in any such action or proceeding; (ii) consents to the service of any complaint, summons, notice or other process relating to any such
action or proceeding by delivery thereof to such Party as set forth in Section&nbsp;7.2 above and (iii) waives any claim or defense in
any such action or proceeding based on any alleged lack of personal jurisdiction, improper venue or forum non conveniens or any similar
basis. EACH OF THE UNDERSIGNED HEREBY WAIVES FOR ITSELF AND ITS PERMITTED SUCCESSORS AND ASSIGNS THE RIGHT TO TRIAL BY JURY IN ANY ACTION
OR PROCEEDING INSTITUTED IN CONNECTION WITH THIS AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.4&nbsp;<U>Entire Agreement</U>. This Agreement sets forth the entire agreement and understanding of the Parties in respect of the transactions contemplated hereby and supersedes all prior and contemporaneous agreements, arrangements and understandings of the Parties relating to the subject matter hereof. No representation, promise, inducement, waiver of rights, agreement or statement of intention has been made by any of the Parties which is not expressly embodied in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.5&nbsp;<U>Assignment</U>. Each Party&rsquo;s rights and obligations under this Agreement shall not be assigned or delegated, by operation of law or otherwise, without the other Party&rsquo;s prior written consent, and any such assignment or attempted assignment shall be void, of no force or effect, and shall constitute a material default by such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.6&nbsp;<U>Amendments</U>. This Agreement may be amended, modified, superseded or cancelled, and any of the terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the Parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.7&nbsp;<U>Waivers</U>. The failure of any Party at any time or times to require performance of any provision hereof shall in no manner affect the right at a later time to enforce the same. No waiver by any Party of any condition, or the breach of any term, covenant, representation or warranty contained in this Agreement, whether by conduct or otherwise, in any one or more instances shall be deemed to be or construed as a further or continuing waiver of any such condition or breach or a waiver of any other term, covenant, representation or warranty of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.8&nbsp;<U>Counterparts</U>. This Agreement may be executed simultaneously in two or more counterparts and by facsimile, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.9&nbsp;<U>Severability</U>.&nbsp;If any term, provisions, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such determination, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.10&nbsp;<U>Interpretation</U>. The Parties agree that this Agreement shall be deemed to have been jointly and equally drafted by them, and that the provisions of this Agreement therefore shall not be construed against a Party or Parties on the ground that such Party or Parties drafted or was more responsible for the drafting of any such provision(s). The Parties further agree that they have each carefully read the terms and conditions of this Agreement, that they know and understand the contents and effect of this Agreement and that the legal effect of this Agreement has been fully explained to its satisfaction by counsel of its own choosing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.11&nbsp;<U>Headings</U>. The headings contained in this Agreement are intended solely for convenience and shall not affect the interpretation of the Agreement or the rights of the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.12&nbsp;<U>Termination</U>. This Agreement may be terminated by the Purchaser by written notice to the Seller, if the Closing has not been consummated on or before the seventh (7<SUP>th</SUP>) business day following the date hereof, <U>provided</U>, <U>however,</U> that no such termination will affect the right of any Party to sue for any breach by any other Party hereto. This Agreement may be terminated by the Seller by written notice to the Purchaser, if the Closing has not been consummated on or before the end of the first business day following the delivery by the Seller of all the Seller Closing Deliverables, <U>provided</U>, <U>however,</U> that no such termination will affect the right of any Party to sue for any breach by any other Party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">[SIGNATURES ON NEXT PAGE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B> the Parties have executed this Agreement as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><B>David Elliot Lazar</B></TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 50%">&nbsp;</TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle"><I>/s/ David Elliot Lazar</I></TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Address for notices:</I></P></TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Unit 44, Tower 100 The Towers<BR>Winston Churchill<BR>San Francisco, Paitilla<BR>Panama City 07196</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Panama</P> </TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">david@activistinvestingllc.com</TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Datuk Dr. Doris Wong Sing Ee</B></P></TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle">&nbsp;</TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; padding-left: -0.25in"><I>/s/ Datuk Dr. Doris Wong Sing Ee</I></TD> </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; padding-left: -0.25in">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Address for notices</I>:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 10, Tower 11</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Avenue 5, No. 8, Jalan Kerinchi</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bangsar South</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Wilayah Persekutuan</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Kuala Lumpur 59200</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Malaysia</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>dorwse@gmail.com</U></P></TD> </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DIRECTOR APPOINTMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ESCROW AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ASSIGNMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 4.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAPITALIZATION SPREADSHEET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 4.11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WARRANTS SUMMARY SPREADSHEET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 4.22</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EMPLOYMENT AND CONSULTANT AGREEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please see data room for all agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 5.10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PRO FORMA BALANCE SHEET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 5.11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FLOW OF EXISTING ISSUER FUNDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>cyclacel_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
      AND ASSUMPTION AGREEMENT</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
      Assignment and Assumption Agreement (&ldquo;<U>Agreement</U>&rdquo;) is made as of February&nbsp;26, 2025 (the &ldquo;<U>Effective
      Date</U>&rdquo;), by and between David Elliot Lazar, whose address is 44, Tower 100 The Towers, Winston Churchill, San Francisco,
      Paitilla, Panama City, Panama 07196 (&ldquo;<U>Assignor</U>&rdquo;), and Doris Wong Sing Ee, an individual residing in Kuala Lumpur,
      Malaysia (&ldquo;<U>Assignee</U>&rdquo;). Assignee and Assignors are referred herein from time to time collectively as the &ldquo;<U>Parties</U>&rdquo;
      and each individually as a &ldquo;<U>Party</U>.&rdquo;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B>&nbsp;Assignor
      and Assignee have entered into that certain Securities Purchase Agreement, dated as of February&nbsp;11, 2025 (the &ldquo;<U>Purchase
      Agreement</U>&rdquo;), pursuant to which Assignor has agreed to sell to Assignee, and Assignee has agreed to purchase from Assignor,
      certain securities of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), as more fully
      described in the Purchase Agreement (the &ldquo;<U>Transaction</U>&rdquo;); and</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B>&nbsp;In
      connection with the Transaction, Assignors have agreed to assign to Assignee, and Assignee has agreed to assume from Assignors,
      the securities purchase agreement between the Company and the Assignor dated February&nbsp;4, 2025 (the &ldquo;<U>Assigned Agreement</U>&rdquo;).</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
      THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree
      as follows:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.
      <U>Defined Terms</U>. Capitalized terms used in this Agreement and not otherwise defined shall have the respective meanings assigned
      to them in the Purchase Agreement.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.
      <U>Assignment</U>. Effective as 12:01 A.M. (Eastern Standard Time) on the Effective Date, Assignor hereby irrevocably, absolutely,
      and unconditionally assigns, transfers, conveys, and delivers to Assignee and its successors and permitted assigns forever all
      of Assignor&rsquo;s right, title, and interest of every kind, nature, and description in, to and under the Assigned Agreement.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.
      <U>Assumption</U>. As of 12:01 A.M. (Eastern Standard Time) on the Effective Date, Assignee hereby accepts assignment of the Assigned
      Agreement, assumes all of the rights and obligations of Assignor under the Assigned Agreement, and agrees to abide by and perform
      all terms, covenants, and conditions of Assignor under the Assigned Agreement.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.
      <U>Further Assurances</U>. Subject to the terms of this Agreement, at the request of a Party, the Parties shall take all reasonable
      and lawful action as may be necessary or appropriate to cause the intent of this Agreement to be carried out.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.
      <U>Successors and Assigns</U>. This Agreement shall be binding upon Assignor and Assignee and their respective successors and assigns.
      The terms and conditions of this Agreement shall survive the consummation of the transfers provided for herein.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.
      <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, regardless
      of the laws that might otherwise govern under applicable principles of conflicts of laws.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.
      <U>Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to
      be an original but all of which shall constitute one and the same agreement. Facsimile copies or &ldquo;PDF&rdquo; or similar electronic
      data format copies of signatures shall constitute original signatures for all purposes of this Agreement and any enforcement hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.
      <U>Entire Agreement</U>. This Agreement, together with the Purchase Agreement, constitute the entire agreement and supersede all
      other agreements and undertakings, both written and oral, among the Parties, or any of them, with respect to the subject matter
      hereof.</FONT></P>
      <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.
      <U>Amendments</U>. This Agreement may not be modified or amended except by a writing executed by the Parties.</FONT></P>
      <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.
      <U>Severability</U>. The provisions of this Agreement are severable, and in the event any provision hereof is determined to be
      invalid or unenforceable, such invalidity or unenforceability shall not in any way affect the validity or enforceability of the
      remaining provisions hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
      Page Follows</I>]</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have caused this Assignment and Assumption Agreement to be executed as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 50%"><B>David Elliot Lazar (Assignor)</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><I>/s/ David Elliot Lazar</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left"><B>Doris Wong Sing Ee (Assignee)</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><I>/s/ Doris Wong Sing Ee</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->




   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>cyclacel_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><B><U>SETTLEMENT AGREEMENT AND GENERAL AND MUTUAL RELEASE</U></B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">This Settlement Agreement and General and Mutual Release (the &ldquo;Agreement&rdquo;) is on this 26th day of February&nbsp;2025 by and between Cyclacel Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;) and Samuel L. Barker (the &ldquo;Director&rdquo;), collectively known herein as the &ldquo;Parties.&rdquo;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>WHEREAS, </B>the Director
      was elected to act as a Member of the Board of Directors of the Company (the &ldquo;Services&rdquo;).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>WHEREAS,</B> the Director has provided the Services commonly performed by a director of a company in a similar position.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>WHEREAS,</B> there is no dispute as to the provision of the Services nor any disagreements with the Company.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>WHEREAS,</B> the Parties desire and intend that this Agreement supplement and modify all prior contracts, agreements and understandings between the Parties.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>WHEREAS, </B>the Parties desire that the Director submits his resignation from the Board of Directors of the Company and from all committees of the Board, if any, on
         which he or she shall be serving on the date hereof, forthwith.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0"><B>NOW, THEREFORE</B>, the Parties, intending to be legally bound, and in consideration of the mutual promises,
         covenants and agreements contained herein and other good and valuable consideration,
         the sufficiency of which is hereby acknowledged, agree as follows:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> 1. <U>Settlement Payments Due to the Director from the Company</U>.</P>


      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">Upon execution hereof, the Company shall pay to the Director a cash settlement payment, including with respect to any and all accrued and unpaid director&rsquo;s fees as of the date hereof as applicable to the Director, in the amount of $50,000 (the &ldquo;Cash Settlement&rdquo;) in immediately available cash, to be transmitted via Bank Wire, in U.S. dollars, in accordance with the following instructions
         to:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>BANK: COMPLETE BANK DETAILS</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Goldman Sacs</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Name on Account: Sam L. Barker</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Routing Number 011302920</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Account Number 26900013097402</B> </P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">or any other address subsequently designated in writing by the Director. It is agreed and understood that time is of the essence with respect to the payments.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> 2. <U>Resignation and Release</U>.</P>


      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The Director hereby resigns as a Member of the Board of Directors of the Company and irrevocably and unconditionally releases, acquits and forever discharges the Company and any principals and any successors and assigns (and any officers, directors, shareholders, managers, members,
         employees, representatives, attorneys, consultants, and agents of such entities) (hereinafter referred to for purposes of this section as the &ldquo;Clients&rdquo;), from any and all claims, demands, rights, causes of action, liens, actions, suits,
         attorneys&rsquo; fees, costs, damages, losses, expenses and contractual obligations of whatever kind
         or nature, whether absolute or contingent, liquidated or unliquidated, direct or indirect,
         in law or in equity, fully accrued or not fully accrued, matured or unmatured, known
         or unknown, foreseen or unforeseen, suspected or unsuspected, relating to any matter whatsoever (collectively, &ldquo;Claims&rdquo;) which the Director had, currently has, shall or may have, <I>provided </I>that the foregoing is not intended to and shall not have the effect of (i) terminating
         or limiting in any way Director&rsquo;s rights to indemnification and advancement of expenses under the Company&rsquo;s Amended and Restated Certificate of Incorporation or Third Amended and Restated Bylaws or Indemnification Agreement or to continued coverage under the D&amp;O
         Policy (as defined in Section&nbsp;3 below), including under the Company&rsquo;s existing Oakwood insurance coverage; (ii) limiting the ability of Director to enforce this Agreement; or (iii) limiting, reducing or eliminating any of the benefits which Director
         is entitled to receive as a holder of equity securities in the Company, including
         the Shares (as defined in Section&nbsp;4 below). Notwithstanding the foregoing, the release contained herein shall not release the Director from their obligations pursuant to this Agreement.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The Company, for itself and for its successors and assigns hereby irrevocably and unconditionally releases, acquits and forever discharges the Director, any successors and assigns (and any officers, directors, shareholders, managers, members,
         employees, representatives, attorneys, consultants, and agents of such entities),
         from any and all Claims (as defined above) which the Company had, currently has, shall or may have. Notwithstanding the foregoing, the release contained herein shall not release the Clients from their obligations pursuant to this Agreement.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">3.&nbsp;<U>Consideration</U>. The Parties understand and agree that this Agreement shall not be construed as (i) an admission of liability by one party to the other,
         (ii) that either party has violated any federal, state or local statute, law, ordinance
         or regulation, or (iii) there has been any material disagreements with the Company. In addition to the Cash Settlement, as full consideration for the release of Claims
         and the other promises and covenants set forth herein and as payment of all amounts
         owed or otherwise payable by the Company to Director for his or her service as a member
         of the Board of the Directors of the Company, the Company shall (i) continue to indemnify
         and advance expenses to Director under the Company&rsquo;s Amended and Restated Certificate of Incorporation and Third Amended, Indemnification Agreement and Restated Bylaws, as permitted by the Delaware
         General Corporation Law and (ii) continue to provide coverage to Director under the
         Company&rsquo;s director and officer liability insurance pursuant to the Company&rsquo;s previously obtained coverage via the AON Tail and present coverage from Oakwood insurance (the &ldquo;D&amp;O Policy&rdquo;). The Company agrees that it will not amend its governing
         documents or modify the coverage of Director under the D&amp;O Policy in a manner that
         would adversely impact Director&rsquo;s rights to any benefits thereunder.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">4.&nbsp;<U>Acknowledgement of Equity Ownership</U>. The Company acknowledges and agrees that the Director, owns 66 shares, 2,626 restricted stock units and 5,704 stock options (collectively, the &ldquo;Shares&rdquo;), respectively, of the Company&rsquo;s common stock, free and clear of all claims of, or encumbrances imposed by, the Company.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">5.&nbsp;<U>No Admission</U>. The Parties understand and agree that this Agreement shall not be construed as (i) an admission of liability by one party to the other, (ii) that either party has violated any federal, state or local statute, law, ordinance or regulation, or (iii) there has been any material disagreements with the Company.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">6.&nbsp;<U>Binding Agreement</U>. This Agreement supersedes all prior agreements between the Parties. This Agreement shall be binding upon the Parties hereto and their respective
         successors and assigns. The Parties agree and stipulate that this Agreement is enforceable
         in all respects and is not subject to any affirmative claim, once this Agreement is executed.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">7.&nbsp;<U>Entire Agreement</U>. This Agreement constitutes the entire and complete understanding between the Parties hereto, and no other representation, promise, or
         agreement shall be binding upon either of them unless it is in writing and executed
         by the Parties.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">8.&nbsp;<U>Amendment</U>. This Agreement may not be amended or modified in any manner except by a writing signed by each of the Parties hereto.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">9.&nbsp;<U>Recitals</U>. The Parties hereto acknowledge and agree that the recitals set forth at the beginning of this Agreement are true and correct in all respects and are incorporated
         herein by this reference.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">10.&nbsp;<U>Governing Law; Venue</U>. This Agreement is made and delivered in and shall be governed by and construed in accordance with, the applicable laws of the State of
         Delaware. Any suit involving any dispute or matter arising under this Agreement, the Parties
         hereby consent to personal jurisdiction in the State of Delaware.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">11.&nbsp;<U>Severability</U>. If any provision of this Agreement is held to be illegal, invalid or unenforceable, the provision shall be modified to the extent necessary to render it
         enforceable and, if necessary, shall be fully severable.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">12.&nbsp;<U>Authority</U>. Each signer below warrants that he/she has actual authority to enter into this Agreement. It is understood that each party to this Agreement is relying on the
         other party executing his Agreement having actual authority to enter into the Agreement.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">13.&nbsp;<U>Counterparts</U>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same Agreement and each of which shall be deemed
         an original. An executed counterpart of this Agreement faxed or scanned and emailed
         shall have the same force and effect as an originally executed counterpart.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">14.&nbsp;<U>Waiver of Jury Trial</U>. EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY PROCEEDING DIRECTLY
         OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">15.&nbsp;<U>Encouragement to Consult Attorney; Time to Consider Agreement</U>. EACH OF THE PARTIES REPRESENTS THAT THIS AGREEMENT HAS BEEN ENTERED INTO FREELY AND VOLUNTARILY;
         THAT IT HAS HAD THE OPPORTUNITY TO ASCERTAIN AND WEIGH ALL OF THE FACTS AND CIRCUMSTANCES
         LIKELY TO INFLUENCE ITS JUDG-MENTS; THAT IT HAS HAD THE OPPORTUNITY TO SEEK AND OBTAIN LEGAL COUNSEL, AND HAS AVAILED
         ITSELF OF COUNSEL PRIOR TO SIGNING THIS AGREEMENT, AND TO BE DULY APPRISED OF ITS
         LEGAL RIGHTS; AND THAT IT HAS READ AND FULLY UNDERSTANDS THE TERMS OF THE AGREEMENT.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">16.&nbsp;<U>Non-Disparagement</U>. The Parties agree that they will not say, write or cause to be said or written, any
         statement that may be considered defamatory, derogatory or disparaging of any of the
         other Parties.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0">IN WITNESS WHEREOF, the Parties have made and entered into this Settlement Agreement and General and Mutual Release as of the date set forth above.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Cyclacel Pharmaceuticals, Inc.</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left"><I>/s/ David Lazar</I></TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 4%">By:</TD>
  <TD STYLE="text-align: left; width: 46%">David Lazar</TD>
  <TD STYLE="text-align: left; width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">Its:</TD>
  <TD STYLE="text-align: left">CEO</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="text-align: left"><B>Director</B></TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left"><I>/s/ Samuel L. Barker</I></TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="text-align: left">Samuel L. Barker</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>cyclacel_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
  <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 99px; width: 250px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><B>CYCLACEL PHARMACEUTICALS ANNOUNCES CLOSING OF A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CHANGE OF CONTROL TRANSACTION AND APPOINTMENT OF NEW</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXECUTIVE LEADERSHIP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>BERKELEY HEIGHTS, NJ, February&nbsp;27, 2025 </B>-- Cyclacel Pharmaceuticals, Inc. (&ldquo;Cyclacel&rdquo;) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on February&nbsp;26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Pursuant to the closing of a Securities Purchase Agreement (the &ldquo;Agreement&rdquo;) between Cyclacel&rsquo;s former interim chief executive officer, David Lazar (&ldquo;Seller&rdquo;) and Datuk Dr. Doris Wong Sing Ee (&ldquo;Purchaser&rdquo;), executed on February&nbsp;11, 2025, Purchaser purchased from Seller, 1,000,000 shares of Series C Convertible Preferred Stock of Cyclacel, $0.0001 par value per share (the &ldquo;Series C&rdquo;) and such number of the 2,100,000 shares of Series D Convertible Preferred Stock of Cyclacel, $0.0001 par value per share (the &ldquo;Series D&rdquo;) held by Seller so that Purchaser owns 70% of the issued and outstanding shares of Cyclacel, which resulted in the issuance of 1,745,262 shares of Series D (collectively, the Series C and Series D, the &ldquo;Securities&rdquo;). The transaction contemplated by the Agreement closed on February&nbsp;26, 2025 (the &ldquo;Closing Date&rdquo;) at which point Purchaser purchased and succeeded to all of Seller&rsquo;s rights and interests under the securities purchase agreement between Seller and Cyclacel dated January&nbsp;2, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Purchaser acquired the Securities for a total consideration of $6,300,000 (the &ldquo;Purchase Price&rdquo;) less a holdback amount of $100,000 (the &ldquo;Holdback Amount&rdquo;) to the escrow agent. The Purchase Price included a cash brokerage fee of $800,000. The Holdback Amount will be held by Purchaser for 120 days from the Closing Date to satisfy any indemnity and other agreed upon claims and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">On the Closing Date, Seller issued written notice to Cyclacel to exercise the conversion rights related to the Series C and Series D shares into the common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;) of Cyclacel registered in Purchaser&rsquo;s name, as follows: (i) 1,000,000 shares of Series C into 2,650,000 shares of Common Stock and (ii) 1,745,262 shares of Series D into 191,978,820 shares of Common Stock. As of the Closing Date, Purchaser has become the new controlling shareholder of Cyclacel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">At the same time, David Lazar resigned as interim chief executive officer and secretary and Datuk Dr. Doris Wong Sing Ee was elected as Chief Executive Officer and Executive Director of Cyclacel. Cyclacel also announced the appointment of Kiu Cu Seng, as Executive Director, Secretary and Chief Financial Officer and, in such role, he will serve as the Company&rsquo;s co-principal financial officer and co-principal accounting officer along with David Lazar until the effective date of his resignation on the earlier of the filing date of the Company&rsquo;s annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2024 or March&nbsp;31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&ldquo;I am honored to serve as Cyclacel&rsquo;s next CEO,&rdquo; said Datuk Dr. Doris Wong Sing Ee. &ldquo;I look forward to our exciting next chapter as I work with the rest of Cyclacel&rsquo;s management team and board of directors to further build our biopharmaceutical business and deliver value for patients, shareholders and our other stakeholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Coinciding with the Closing Date, the following directors of the Company tendered their resignation or notice of resignation from the Board: (i) Dr. Samuel L. Barker resigned as an independent director; (ii) Avraham Ben-Tzvi provided notice that his resignation as an independent director will be effective upon the earlier of the filing date of the Company&rsquo;s annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2024 or March&nbsp;31, 2025; (iii) Paul McBarron resigned as a non-independent director; (iv) David Natan provided notice that his resignation as an independent director will be effective upon the earlier of the filing date of the Company&rsquo;s annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2024 or March&nbsp;31, 2025; and (iv) Spiro Rombotis resigned as a non-independent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">In connection with the resignation of Messers. Barker, McBarron and Rombotis, effective as of February&nbsp;26, 2025, the Board appointed Chong Kwang Fock to act as an Independent Director, as well as the Board appointments of Datuk Dr. Doris Wong Sing Ee and Kiu Cu Seng, as noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>About Datuk Dr. Doris Wong Sing Ee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Datuk Dr. Doris Wong Sing Ee is a seasoned leader with more than 20 years of management experience across various industries ranging from oil and gas, property development, solar, engineering, advertising, food and beverage, raw materials and more. She specializes in business development, strategic consultancy and corporate advisory in mergers and acquisition and joint venture across Malaysia, Singapore, China, Japan, Thailand and Indonesia. Datuk Dr. Doris Wong Sing Ee has also been serving as the Executive Director of BSL Corporation Berhad (KLSE: BSLCORP) since May&nbsp;2024, a public listed company with its business segments constituting stamping and manufacturing of precision metal parts and fabrication of tools and dies, printed circuit boards (PCB) assembly of all types of electronics and electrical components, devices and systems, fabrication and forging of base metal components for consumer products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Since October&nbsp;2020, Datuk Dr. Doris Wong Sing Ee has been serving as an Executive Director of Metronic Global Bhd, an investment holding company, where she has been optimizing financial operations, establishing business goals, advising the board of directors on organizational activities and executing special business projects. She has also been involved in various investment opportunities in business diversification, generating new revenue and increasing shareholders&rsquo; wealth. Datuk Dr. Doris Wong Sing Ee served as an independent director and member of the audit committee and the compensation committee of Energem Corp since from its initial public offering on November&nbsp;16, 2021 until her appointment as Executive Director on January&nbsp;27, 2023. Following Energem Corp&rsquo;s completion of a series of transactions that resulted in its business combination with Graphjet Technology Sdn. Bhd. (Nasdaq: GTI), a Malaysian private limited company (&ldquo;Graphjet&rdquo;) on March&nbsp;14, 2024, Datuk Dr. Doris Wong Sing Ee served as a director of Graphjet until January&nbsp;6, 2025. Since February&nbsp;2017, Datuk Dr. Doris Wong Sing Ee has been a non-independent non-executive director at Trive Property Group Bhd (0118.KL). Previously, from January&nbsp;2019 to September&nbsp;2020, Datuk Dr. Doris Wong Sing Ee served as Chief Corporate Officer in Metronic Engineering Sdn. Bhd. (0043.KL) where she oversaw HR operations, set objectives for the HR team and helped shape the brand strategy of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>About Kiu Cu Seng</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Mr.&nbsp;Kiu brings significant accounting and audit experience involving publicly listed companies during his years working with accounting standards to the Company. Mr.&nbsp;Kiu served as Energem Corp&rsquo;s Chief Financial Officer from August&nbsp;12, 2021 through its completion of a series of transactions that resulted in its business combination with Graphjet on March&nbsp;14, 2024. Since March&nbsp;2021, Mr.&nbsp;Kiu has served as Group Accountant for BCM Alliance Bhd, Sanichi Technology Bhd. and Trive Property Group Bhd. His responsibility is on group consolidation issues. From June&nbsp;2019 to February&nbsp;2021, Mr.&nbsp;Kiu served as Manager in SBY &amp; Partners PLT (formerly known as Siew Boon Yeong &amp; Associates) an established professional accounting organization providing a comprehensive range of services ranging from audit and assurance, taxation and accounting where he specialized in auditing matters. From June&nbsp;2017 to February&nbsp;2019, Mr.&nbsp;Kiu served as a Senior Auditor with Siew Boon Yeong &amp; Associates. Mr.&nbsp;Kiu graduated from Infrastructure University Kuala Lumpur in 2013 with a bachelor&rsquo;s degree (with Honors) in Accounting and from Kuala Lumpur Infrastructure University College with a Diploma in Accounting in 2009.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>About Chong Kwang Fock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Kwang Fock Chong is a Chartered Accountant in Malaysia, and brings nearly 20 years of the working experience to the Company. He served as an Independent Director, Chair of the Audit Committee and member of the Compensation Committee of Energem Corp since its initial public offering on November&nbsp;16, 2021 until its business combination with Graphjet on March&nbsp;14, 2024. His experience includes auditing of public listed companies, multinationals and private limited companies in various industries. Other than conducting statutory audit in Malaysia, he also performed audit for companies based in China and the AIPAC region. He was also involved in Reporting Accountants&rsquo; engagement on initial public offering exercise, due diligence, reviewing financial forecast and projections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Mr.&nbsp;Chong serves as Auditors and Partner of KHLC PLT where his main responsibility is reviewer and signing partner since October&nbsp;2020. From July&nbsp;2014 to September&nbsp;2020, Mr.&nbsp;Chong served as Auditor and Partner of SBY Partners PLT that provides audit and assurance services. His main responsibility was reviewer and signing partner. Mr.&nbsp;Chong received his Diploma in 2002 from Tunku Abdul Rahman College in Financial Accounting. He achieved his Association of Chartered Certified Accountants certification in 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Advisors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rimon P.C. served as legal counsel to Datuk Dr. Doris Wong Sing Ee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ABZ Law Office served as legal counsel to David Lazar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>About Cyclacel Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel&rsquo;s strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Forward-looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">This press release includes forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, Section&nbsp;21E of the Securities Exchange Act of 1934, as amended and the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995, and encompasses all statements, other than statements of historical fact contained in this press release. These forward-looking statements can be identified by terminology such as &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;aims,&rdquo; &ldquo;future,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;targets,&rdquo; &ldquo;likely to&rdquo;, &ldquo;understands&rdquo; and similar statements. These forward-looking statements are based on management&rsquo;s current expectations. However, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors and circumstances that may cause Cyclacel&rsquo;s actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including conditions in the U.S. capital markets, negative global economic conditions, potential negative developments resulting from epidemics or natural disasters, other negative developments in Cyclacel&rsquo;s business or unfavorable legislative or regulatory developments. We caution you therefore against relying on these forward-looking statements, and we qualify all of our forward-looking statements by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">For a discussion of additional factors that may affect the outcome of such forward-looking statements, see our 2023 annual report filed with the SEC on Form 10-K on March&nbsp;21, 2024, as amended on April&nbsp;30, 2024 (Commission File Number: 000-50626), and in particular the &ldquo;Risk Factors&rdquo; section, as well as the other documents filed with or furnished to the SEC by Cyclacel from time to time. Copies of these filings are available online from the SEC at <U>www.sec.gov</U>, or on the SEC Filings section of our Investor Relations website at <U>https://investor.cyclacel.com/sec-filings</U>. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management&rsquo;s estimates as of the date of this press release. These forward-looking statements should not be relied upon as representing Cyclacel&rsquo;s views as of any date subsequent to the date of this press release. All forward-looking statements in this press release are based on information currently available to Cyclacel, and Cyclacel and its authorized representatives assume no obligation to update these forward-looking statements in light of new information or future events. Accordingly, undue reliance should not be placed upon the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><B>Investor Relations Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">IR@cyclacel.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !W 2X# 2(  A$! Q$!_\0
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M%% !1110 4444 %%%% !1110 44=!DU''/#-GRI4DQUVL#B@"2BBB@ HHHH
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MFZ'F16EFVS8IZ9'0<=JUK+X6>(]#U>SNM+\<:A-;1S*TUO=LS;T!Y&<GM[4
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MX:15;X<7JJ2 3YO3]*QOCT0NK^#F8@ 7A)).,?,E>P?VQI?_ $$K/_O^O^-
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144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "* 5P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7L/C*!([F&4+"Z  2)CKQUYKS:Z\:?$36?B5K'ASP]>6JBUE?RUFC4 (OO\
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M* &)#%%_JXT3_=4"GD ]:** $V+_ '1^5&U1T4?E2T4 ( !T I:** #KUI
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M\%_P"@FH32C,6GW&#T,F%'\ZD2.[E),[K$G:.+D_BW_UJMU%-<P6XS-*B9Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cycc-20250226.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +KIpo7xRiXgen8uAZHZcOaKJWbPtxZ97iekhsmR3bakajy0i72stVSZ+00Tm8cgB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cycc="http://cyclacel.com/20250226" elementFormDefault="qualified" targetNamespace="http://cyclacel.com/20250226">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cyclacel.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250226_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="cycc_CommonStockParValue0.001PerShareMember" name="CommonStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cycc_PreferredStock0.001ParValueMember" name="PreferredStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cycc-20250226_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cyclacel.com/role/Cover" xlink:href="cycc-20250226.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_CommonStockParValue0.001PerShareMember" xlink:label="loc_cyccCommonStockParValue0.001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cyccCommonStockParValue0.001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_PreferredStock0.001ParValueMember" xlink:label="loc_cyccPreferredStock0.001ParValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cyccPreferredStock0.001ParValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cycc-20250226_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_CommonStockParValue0.001PerShareMember" xlink:label="cycc_CommonStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cycc_CommonStockParValue0.001PerShareMember" xlink:to="cycc_CommonStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cycc_CommonStockParValue0.001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_PreferredStock0.001ParValueMember" xlink:label="cycc_PreferredStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cycc_PreferredStock0.001ParValueMember" xlink:to="cycc_PreferredStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cycc_PreferredStock0.001ParValueMember_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cycc-20250226_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cyclacel.com/role/Cover" xlink:href="cycc-20250226.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_CommonStockParValue0.001PerShareMember" xlink:label="loc_cyccCommonStockParValue0.001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cyccCommonStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250226.xsd#cycc_PreferredStock0.001ParValueMember" xlink:label="loc_cyccPreferredStock0.001ParValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cyccPreferredStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45760601987424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 26,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cyclacel Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1707622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Connell Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Berkeley Heights<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">517-7330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cycc_CommonStockParValue0.001PerShareMember', window );">Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cycc_PreferredStock0.001ParValueMember', window );">Preferred Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCCP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cycc_CommonStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cycc_CommonStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cycc_PreferredStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cycc_PreferredStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MGS2%KF+<L!.,(WF.(3"+\1G-,F1W,OC$^X.=DC3-\S@"6)Q!FF((G$8<P1@
M!PQ)T_X]>/<^2L;W5'+YC[#Y"5!+ P04    " "F@%M:EXJ[',     3 @
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MY68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B?
M:ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G6
M0VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_
M,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " "F@%M:)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ IH!;6F60>9(9 0
MSP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F
M&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\
M% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY
M&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J
M>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q
M32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1
MS>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M    " "F@%M:!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( *: 6UJYA&=D[@   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ IH!;6JK$(A8S 0  (@(   \
M     ( !H1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *: 6UHD'INB
MK0   /@!   :              "  0$2  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( *: 6UIED'F2&0$  ,\#   3
M  "  >82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  # 4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="cyclacel_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyclacel.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cycc-20250226.xsd</File>
    <File>cycc-20250226_def.xml</File>
    <File>cycc-20250226_lab.xml</File>
    <File>cycc-20250226_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cyclacel_8k.htm">cyclacel_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cyclacel_8k.htm": {
   "nsprefix": "cycc",
   "nsuri": "http://cyclacel.com/20250226",
   "dts": {
    "schema": {
     "local": [
      "cycc-20250226.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cycc-20250226_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cycc-20250226_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cycc-20250226_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "cyclacel_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://cyclacel.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cyclacel_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cyclacel_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "auth_ref": []
    },
    "cycc_CommonStockParValue0.001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250226",
     "localname": "CommonStockParValue0.001PerShareMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cycc_PreferredStock0.001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250226",
     "localname": "PreferredStock0.001ParValueMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001829126-25-001253-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001829126-25-001253-xbrl.zip
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MS30)6PF\..]I4*A+'YT>CT8_F;+_7@*I[8/NPY*8+M@+!J5ZD0CSJFW@8BU
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M8U!V1XEMRFPJR!J)[8R$S0/+/M8#X:V40>4=9;,IM5NTF42Z$61!TD6IS08
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M!%&:CUGC'[/L"A)PY\\*[;34,&-0=D<IYXQ3$FJ%V/*;;H<@B-HUK^(Z+3A
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MS<Q!.YS>.?W!:<P4$LF26P$<&U:H!_+;&(.R.[U)FBTKWYVYTK=TUJEOC_#
MA!KBH!=.;YY.F,("A8H\XB](H8QOG1?V" ^\J"$.>N%TX7%RH(YU>Y:\?NU
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M5IKDT(K]/"AK#?I!B95XQ7%[JK4*<-<PE X=XKF4Z*!F+MKG[V(\UA)]%WT
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M*P;V0059!DV\KJPO3@FE4<8VL@.4TL&JU&/A&$T\JS^D]0 DKM' 6>;$WYL
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MK./!V>C@GJ3[]@"^QYHOBP\S>7(^=OF)VU?P^'KQ!$>+7"% 5<(F-^4?B:\
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MTNQ'A4J!?L+"B'7CXYHP+1[J5G"$E/TZ3YCSP('%>3T"'E<A;\*M :D?P^$
MAQ"-A00M8@$X]DS$+X$"Z0B3*$EK8';RB+T5J+46.?(H5WPG=@>W;9(44U=
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M)CH#^3W^MFA\77=<>N+BTAF=2T^B^(4XJT0$+G,$F3Y&(2L31 ;*XD&@N8D
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M5W]MPP,T!9#VH>NP^[$YTK2F%0@._RNP<V4[.OEM(D #1GD+\[>HC)%J8!>
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M1?];8?K;5?+Y%_ ZRB[+J @&>8TNO,\]W;LDC>;1%94-4N_KJHZRSS_IOVL
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MVKH$74-&2"!U!=Z&5(\ G&B6*9DI#O:$RD44PA8[%)*PMY]:  .M0$A$E>*
M/9GO4'<?J'M51=VD[HH=,13("^N[YY #&SC%,KJ8DSS#\Q?/+K5:1%$IX*H:
MBVZY_<+9E]J$);JO<IAI4@7L9,F+D!<SJ3Q-7;&MX.(R-B$ U"40:6S3,'>\
ML(/>/4#O=15Z;\!I*4Q.R#E=_37BYK8I[%_A"7&WC<I=E@2N6ZH8&7-34@,"
MTQX&$!  0\&%+\P& ,HY1 @)@+$27I;];,D[14=>2;6<"H4/!>I+>&13>"!
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MD%9\$53+M)")$1,M.2>"D5Q@K;B(TYSUJCXL05 9?;@"GJJ5= I;9/_)3=F
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MBB[%G?3"6_'F7/MH,H8C<%P1S4?*+B0P^L-X,MJGM\.+J\OG F+"OI[)$G*
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MI5,SM(VUKTGS+1V(Q9]DQW)5==/[1XCQHG#](77.KC^C^D8 _M8>$PK2C1W
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M?X.CYR]V;/$9A6/K'581Y_QW2L!WK[?]JO=Z]_7SCF\OY'JD#@IR*8TKZ%>
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M5Z6NRRHH* B**:LIR:G*R"O(_34(Z (M[47ZBUP,#%QRE_DNR_W70?X,,%\
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M,C(V7V1E9BYX;6Q02P$"% ,4    " "F@%M:PJ4S;^(+  #2CP  %0
M        @ $8#0  8WEC8RTR,#(U,#(R-E]L86(N>&UL4$L! A0#%     @
MIH!;6B\S=Y\["    &,  !4              ( !+1D  &-Y8V,M,C R-3 R
M,C9?<')E+GAM;%!+ 0(4 Q0    ( *: 6UIOB4'BI3(   4Y 0 /
M      "  9LA  !C>6-L86-E;%\X:RYH=&U02P$"% ,4    " "F@%M:X WV
MJ*PY   O,P$ $P              @ %M5   8WEC;&%C96Q?97@Q,"TQ+FAT
M;5!+ 0(4 Q0    ( *: 6UKFX8KV=0H  #<_   3              "  4J.
M  !C>6-L86-E;%]E>#$P+3(N:'1M4$L! A0#%     @ IH!;6M2^/E<K$@
MT%(  !,              ( !\)@  &-Y8VQA8V5L7V5X,3 M,RYH=&U02P$"
M% ,4    " "F@%M:,CD.S%D6  "?5   $P              @ %,JP  8WEC
M;&%C96Q?97@Y.2TQ+FAT;5!+ 0(4 Q0    ( *: 6UH/7 >G#!4  )$6   +
M              "  =;!  !I;6=?,# Q+FIP9U!+!08     "@ * (("   +
%UP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>cyclacel_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cycc="http://cyclacel.com/20250226"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cycc-20250226.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cycc:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cycc:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-26" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-26" id="Fact000004">0001130166</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-02-26" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-26" id="Fact000010">2025-02-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-26" id="Fact000011">Cyclacel Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-26" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-26" id="Fact000013">0-50626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-26" id="Fact000014">91-1707622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-26" id="Fact000015">200 Connell Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-02-26" id="Fact000016">Suite 1500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-26" id="Fact000017">Berkeley Heights</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-26" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-26" id="Fact000019">07922</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-26" id="Fact000020">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-26" id="Fact000021">517-7330</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-26" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-26" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-26" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-26" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000026">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000027">CYCC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember"
      id="Fact000029">Preferred Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember"
      id="Fact000030">CYCCP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_PreferredStock0.001ParValueMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-26" id="Fact000032">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
